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If you could take a snapshot of our Society just 12 m o n t h s
ago, and then hold it up against another taken today, the
p ro g ress you’d see would be astonishing. Every year since
our founding in the mid 1990s, we’ve taken major leaps for-
w a rd in service to our field and to our members, and I can
a s s u re you that these past 12 months have been no exception.
The unifying theme of this past year has been “communi-
c a t i o n s ” … p rograms to strengthen our voice as an advocate for
B M T … p rograms to facilitate the flow of knowledge between
l a b o r a t o ry scientists and clinicians…programs to enhance the
exchange of information with and among our members.
Our achievements this year were made possible by the
enthusiastic and effective work of our Board of Dire c t o r s
and committees, and the loyal support of our members.
Here are some highlights.
BBMT: Six full issues of the Biology of Blood and Marrow
Transplantation have been published—on time I must add—
in 1999. We are planning 12 issues in 2000, which will
s i g n i ficantly increase the impact of the journal, reduce the
time from submission to publication and stimulate an even
higher quality of manuscripts. 
The goal is to make BBMT the flagship of the field and
our society. Dr. Karl Blume and Dr. Richard O’Reilly must
be congratulated for taking our journal to this new level
during their term as co-editors. The original research arti-
cles have been excellent, and many people have commented
to me on the excellent quality of the review articles. 
The publications committee has recommended, and our
B o a rd enthusiastically endorsed, the appointment of Dr.
Robert Korngold as our new editor starting in 2001. 
Membership Dir e c t o ry : A major milestone for the
Society was the debut of our first published membership
d i re c t o ry. Now we know exactly where to find colleagues,
how to call them up, write them a letter or send them an
e -mail. The ASBMT Directory also provides an overview of
our organization and its committee structure, as well as its
history, goals and bylaws. 
Members are urged to contact committee members to
offer suggestions on how the Society can advance the field
or help provide improved services.
P re s i d e n t ’ s Newsletter: I hope you’ve noticed and
have benefited from the P re s i d e n t ’s Desk n e w s l e t t e r. It was
launched this past year as a way to rapidly bring you up to
date on the Society’s activities. The items are timely and
staccato – designed for a “quick read.” Members are encour-
aged to submit announcements or short informative items
that would be of immediate interest to the membership.
Annual Meeting: If you attended last year’s Annual
Meeting, there’s not much more that I can tell you here. It
was excellent. Clearly the meeting is equal to the journal as
a communications forum for our clinical and laboratory
members, as well as our colleagues in associated disciplines.
The decision to hold our annual meetings back-to-back
with the IBMTR/ABMTR Annual Participants’ Meeting
p roved popular with everyone, as evidenced by the more than
1,300 who attended the sessions in Keystone. A synergistic
and successful relationship has been established with
IBMTR/ABMTR, making the “Tandem BMT Meetings”
the leading annual event in the field of hematopoietic stem
cell biology and transplantation. 
And we haven’t seen anything yet, given the pro g r a m
that Dr. Keith Sullivan has in store for us in March in
A n aheim. New this year will be a series of state-of-the-art
sessions, interactive workshops and poster sessions, a grant-
writing workshop, a Doctors’ Job Fair, a conference for
BMT administrative directors and—lest we fall into the trap
of all work and no distractions—more than a dozen local
tours. The dates are March 26-April 1.
Then next year, as we plan to do every second year, we
will re t u rn to Keystone Resort and its conference center
that has been newly enlarged to accommodate our growth. 
Evidence-Based Reviews and Position Statements:
Much needed evidence-based reviews and position state-
ments on BMT for various diseases are now under way,
thanks largely to the efforts of Dr. Fred LeMaistre. These
p romise to provide a firm basis for addressing re i m b u r s e-
ment issues, as well as re g u l a t o ry and legislative concern s .
They also will help us communicate with re f e rring physi-
cians, patients and corporate supporters.
N o n - H o d g k i n ’s lymphoma will be the first area to be
addressed by this important new initiative. You will be hear-
ing much more about this. 
Awards: It is important to recognize and communicate
our achievements and successes. This year we have added a
second New Investigator Aw a rd sponsored jointly with
Roche Laboratories. This two-year award is similar to the
Fujisawa program that we launched last year and is wort h
$25,000 per annum. It means that an award will be available
each year to an outstanding young investigator who is a
member, or sponsored by a member, of our Society. 
Other important awards are the BBMT E d i t o r i a l
Aw a rds of $5,000 each for the best clinical science paper
each year (the George Santos Award) and the best basic sci-
ence paper (the Ernest McCulloch and James Till Award).
We also honor a member of our field each year with the
E. Donnall Thomas Lecture, and someone outside our pro-
fessional membership with the ASBMT Public Serv i c e
Aw a rd. All of these awards recognize and encourage
achievements that benefit our field and our patients.
Administrative  Manual: It may seem somewhat
“behind the scenes” to many members, but one of our most
important achievements in internal communications was the
publication of our first Policies and Pro c e d u res Manual.
The book clearly and concisely codifies the responsibilities
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and duties of our Board of Directors and officers, our coun-
cils and our committees. It precisely describes the policies,
administrative functions, timelines and expected outcomes
necessary to make our Society run smoothly and effectively.
The book details the committee stru c t u re in terms of
charter, membership, tenure and responsibilities. Copies are
available to members upon request should they wish more
information about how the Society functions. 
A c c re d i t a t i o n : As you probably know, ASBMT is one
of the two corporate parents of the Foundation for the
A c c reditation of Hematopoietic Cell Therapy (FA H C T ) ,
the voluntary accrediting agency for BMT collection, pro-
cessing and transplant facilities. FAHCT allows us to com-
municate our standards and vision of how the field of blood
and marrow transplantation should manage itself. 
Together with the other corporate parent, the Intern a-
tional Society of Hematotherapy and Graft Engineering
(ISHAGE), we are extremely pleased with the gro w i n g
number of transplant centers that are being accredited. We
all owe a debt of gratitude to Dr. E. J. Shpall, the founda-
t i o n ’s president, and Dr. Phylis Warkentin, chair of the
a c c reditation committee, for their tremendous eff o rts in
bringing this program to its current level of re c o g n i t i o n
and stature. 
In closing, I want to thank the membership for support-
ing the Society, which is clearly becoming a major force in
moving forward the field of blood and marrow transplanta-
tion. Most important, I want to thank the Executive Com-
mittee and our Executive Director Alan Leahigh for their
commitment and support. Finally I want to wish Dr. Jim
Armitage, your new president, every success as he takes up
the challenge of now leading us forward. 
Allen C. Eaves, MD, PhD
The American Society of Blood and Marrow Transplan-
tation is approaching a cro s s roads. We have successfully
o v e rcome the many problems involved in starting a new
society. We have grown significantly in size.
The most important accomplishments of any society,
and a guarantee of financial security, are the annual meeting
and the journal. Our annual meeting has grown in size,
quality, and financial success. In this regard, we have greatly
benefited from our association with the International Bone
M a rrow Transplant Registry. Due to the extraord i n a ry
efforts of Dr. Karl Blume and Dr. Rich O’Reilly, our journal
has succeeded. By hard work and an uncompromising com-
mitment to quality, they have developed a journal of which
we can all be proud.
We now have to build on these successes. We need to
increase the quality and quantity of proffered papers at our
annual meeting. We need to understand the issues most
important to our members and to address them. Our society
has many talented individuals and we need to involve them
in the work of the society in increasing numbers. It will be
important to develop the most effective relationship that we
can have with our European colleagues. It may be that there
are unexplored but important areas of cooperation and col-
laboration. With good fortune and hard work, our society
can have a bright future.
James O. Armitage, MD
Professor of Medicine
A Message from the New ASBMT President
